Treatment.com International (CSE:TRUE, OTCQB:TREIF) Inc. CEO John Fraser tells Proactive its medical education product is 'jumping forward' as it is being used to standardize the teaching and testing of medical students. Fraser says the group is going to market with its three different products and has 'many large deals in the pipeline.' He adds the over the next year there may be announcements on new contracts with large systems to incorporate Treatment's AI into clinical workflows.
Treatment.com updates on its three AI-focused digital healthcare technologies
